Canakinumab Subcutaneous and Oxsoralen-Ultra

• Generic Name: canakinumab
• Dosage Forms: n.a.
• Other Brand Names: Ilaris

Canakinumab injection is used to treat cryopyrin-associated periodic syndromes (CAPS). This also includes familial cold auto-inflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS). CAPS is a rare, inherited disease of the immune system. It occurs when the body produces too much of a chemical called interleukin-1 beta. This chemical causes inflammation, and patients with CAPS may have a fever, headache, skin rash, joint or muscle pain, or unusual tiredness or weakness.

Canakinumab helps prevent inflammation by keeping the interleukin-1 beta from working properly. Canakinumab also treats adults and children with other autoinflammatory periodic fever syndromes, such as tumor necrosis factor receptor associated periodic syndrome (TRAPS), hyperimmunoglobulin D syndrome (HIDS)/mevalonate kinase deficiency (MKD), and familial Mediterranean fever (FMF).

Canakinumab is also used to treat active systemic juvenile idiopathic arthritis (SJIA) in children 2 years of age and older.

Canakinumab is to be given only by or under the direct supervision of a doctor.

• Generic Name: methoxsalen
• Dosage Forms: capsule, liquid filled
• Other Brand Names:

  8-Mop, Oxsoralen-Ultra, Uvadex

Oxsoralen-Ultra works by enhancing the body's sensitivity to ultraviolet light A (UVA).

Oxsoralen-Ultra is used in combination with UVA light therapy to treat severe psoriasis.

Oxsoralen-Ultra can cause harmful effects on your vision and on your skin (premature aging or skin cancer). Oxsoralen-Ultra is used only for severe psoriasis that has not improved with other treatments. You must remain under the care of a doctor while taking this medicine.

Oxsoralen-Ultra may also be used for purposes not listed in this medication guide.